Atlas Trials

Solid Tumors Harboring MET Amplification

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Solid Tumors Harboring MET Amplification

RecordFirmDate
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan (NCT07196644)AbbVie2025-12-01

Track Solid Tumors Harboring MET Amplification automatically

Every clearance here is in the API, with alerts when new ones post.